WD-1603 Carbidopa-Levodopa Extended-Release Tablets

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05128175 (ClinicalTrials.gov)	October 29, 2021	27/10/2021	Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release TabletsUnder Fasting and Fe ...	An Open-label, Balanced, Randomized, Five-treatment, Five-period, Five-sequence, Multiple Oral Dose, ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	15	Phase 1	India
2	NCT05036473 (ClinicalTrials.gov)	October 12, 2021	10/8/2021	A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tabletsin Patients With Pa ...	A Phase II Randomized, Parallel, Double-blind, Placebo-controlled, Multi-center Clinical Trial of th ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets;Drug: Placebo	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	30 Years	75 Years	All	40	Phase 2	China

First Previous1Next Last